戻る Agenda
Session 7: AI and PV – Current Implementations and Future Directions
Session Chair(s)
Jamie Portnoff
Partner, Co-Founder
Truliant Consulting, United States
Jeremy Jokinen, PhD, MS
Vice President and Head, Safety Evidence and Sciences
Bristol-Myers Squibb Company, United States
This session will examine current uses of artificial intelligence (AI) across the industry and look at future opportunities to leverage AI from an industry and regulatory perspective. Discussions will include both analytic tools and platforms, like multitenant safety databases, which are key enablers to leveraging future-state tools across the industry.
Learning Objective : At the conclusion of this session, participants should be able to:
- Discuss current-state applications of AI in PV
- Understand future opportunities and limitations of the use of AI in PV
- Understand the changing regulatory environment with respect to these technologies
Speaker(s)
Current Implementations of AI and Lessons Learned from COVID-19
Patrick M. Caubel, MD, PhD, MBA
Pfizer Inc, United States
Chief Safety Officer
Multitenant Solutions to Enable Future Analytics Solutions
Michael Richardson, MD, FFPM, FRCP
Bristol-Myers Squibb, United Kingdom
Senior Vice President, WorldWide Patient Safety
Automation/AI and process orchestration – National Agency and Industry examples
Martin Holm-Petersen
Insife Inc, United States
CEO